Allogene Therapeutics: 4Q Earnings Snapshot

February 27, 2020 GMT

SOUTH SAN FRANCISCO, Calif. (AP) _ Allogene Therapeutics Inc. (ALLO) on Thursday reported a loss of $61 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 58 cents.

The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.

For the year, the company reported that its loss narrowed to $184.6 million, or $1.83 per share.

Allogene Therapeutics shares have fallen 2% since the beginning of the year. The stock has dropped 20% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO